Scientific Zambon Pharma 11 Luglio 2017 XADAGO® (SAFINAMIDE) NOW AVAILABLE IN THE U.S. FOR PARKINSON’S DISEASE PATIENTS
Institutional Zambon Pharma 11 Aprile 2017 Valeo Pharma and Zambon form partnership for Parkinson’s Disease Treatment Xadago® (safinamide) in Canada
Scientific Zambon Pharma 10 Aprile 2017 ZAMBON LAUNCHES XADAGO® (SAFINAMIDE) IN PORTUGAL FOR PATIENTS WITH MID- TO LATE-STAGE PARKINSON’S DISEASE
Scientific Zambon Pharma 21 Marzo 2017 FDA APPROVES XADAGO® (SAFINAMIDE) FOR PARKINSON’S DISEASE (PD) PATIENTS
Institutional Zambon Pharma 10 Gennaio 2017 Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand
Institutional Zambon Pharma 2 Novembre 2016 Agreement Zambon - Fabbrica Italiana Sintetici (FIS) for the development of the Lonigo plant